I must admit Beep's so called Bio people were right on the money with PVA's 24 month data that it's seen Aimera's & PVA's share price smashed NOT in recent weeks. ALIM is trading at it's list price & PVA consolidating at the $5.60/90 mark.
With the 3 year results due early this month I can't help but think we could see another kick before the FDA approval date arrives.
aust life science investment summit, page-2
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)